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Reduced genomic tumor heterogeneity after neoadjuvant
chemotherapy is related to favorable outcome in patients with
esophageal adenocarcinoma
SUPPLEMENTARY FIGURES AND TABLE
Array CGH data preprocessing
After computing log2 ratios, missing values 
were imputed using a k-nearest neighbor algorithm 
implemented in the R-package ‘impute’ available from 
Bioconductor. Missing values were imputed if values of a 
particular feature were available from more than 30% of all 
experiments. By applying this imputation procedure, the 
total number of features was reduced to 173,367 features. 
Afterwards, CGH profiles were wave bias corrected by 
regressing them on a calibration set containing 16 normal 
profiles to improve detection of aberrations [1]. In a last 
preprocessing step, microarray data was global median 
normalized and tumor % corrected using an approach 
described by van de Wiel et al [2]. Subsequently, copy 
number profiles were inspected visually. The median 
cellularity of remaining 75 samples is 60%. The final data 
matrix that has been used for downstream analysis was 
of size 173367 × 75. Normalization, tumour cellularity 
correction and segmentation were performed with the 
R-package CGHcall was used for preprocessing and 
segmentation.
Mathematical description of the entropy 
calculation steps
In our setting, entropy measures how far a particular 
sample is away from the rest in p-dimensional genomics 
space. Specifically, entropy of sample Si is calculated in 
the following way: first, the kth-nearest neighbor of Si is 
determined, which will be used to estimate the probability 
density function:
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where n is the total number of samples, p is the 
number of features, Vp is the volume of a unit ball in 
p dimensional space, dk(Si) is the Euclidean distance 
between Si and its kth nearest neighbor. Finally, the 
entropy of Si is equal to
( )= −H S f S( ) log ( )i i
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Supplementary Figure S1: Schemata of the averaged CGH profile generation from a given segmented data. For each 
sample its segmented data values were first divided into positive and negative parts, roughly equal to gain and loss. The positive values 
across samples were averaged to calculate mean positive segmented values. The mean negatives segmented values were generated in 
similar ways. Finally, they were plotted together in barplots to illustrate the averaged DNA copy number aberration patterns in a given 
segmented data.
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Supplementary Figure S2: Comparing tumor cells/area between treatment groups. A. Example of HE stained section with 
high number of tumor cells/area (85%). Bar = 300μm B. Example of HE stained section with low number of tumor cells/area (20%) due 
to the infiltration of the tumor with many inflammatory cells. Bar = 300 μm Note that all HE stained slide from the cases used in this study 
have been scanned and are viewable via the internet upon request to H.Grabsch@maastrichtuniversity.nl. C. Bean plot comparing the 
tumor cells/areas distribution between the treatment groups. The shape and the mean (blue line) of tumor cells/areas are relatively different 
between the treatment groups. S (right) appears to be composed of samples with low tumor cells/area whereas the opposite holds true for 
CS (left).
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Supplementary Figure S3: Tumor cells/area difference vs. DNA copy number entropy difference by treatment arm. 
Top row shows the distributions of samples from CS A. and S B. in the space defined by their first two principal components obtained 
from the segmented data matrix. We also divided samples in each treatment arm into two groups (low and high cellularity) according to 
the percentage of tumor cells/area using the median as cutoff. Then, samples were again projected onto the space spanned by the first two 
principal components. We observed that there was no considerably difference in scatterness between the high and the low tumor cells/area 
groups within each treatment arm, e.g. C. vs E. and D. vs F. There was also no considerably difference in scatterness between the low 
tumor cells/area group in CS C. and the high tumor cells/area group in S F. Hence, we concluded that the observed difference between the 
treatment groups was not due to the difference in tumor cells/area but was indeed related to the treatment group specific aberration patterns 
present in the CGH profiles. In each panel, a point denotes a sample, and the shape and color corresponds to one of the tumor cell/area 
percentages shown in the legend box on the right. To complement the visualization in Supplementary Figure S3, we also conducted a formal 
statistical test. Namely, we tested the statistical significance of the group differences in terms of DNA copy number entropy in relation to the 
tumor cells/area by a simple regression. The DNA copy number entropy was used as response variable, whereas the treatment-arm indicator 
and the percentage of tumor cells/area were used as independent covariates. Regression result showed that the treatment-arm indicator was 
a strong predictor (coeff. =0.216, p-value=0.004), while no significant association was observed for the tumor cells/areas (coeff. =-0.002, 
p-value=0.29). Thus, we confirmed that the observed differences between the two treatment group indeed were not due to the tumor cells/
area.
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Supplementary Figure S4: Association of DNA copy number entropy with cancer specific survival. The whole cohort was 
divided into three equal sized patient groups based upon the DNA copy number entropy values. Patients in the low entropy group (n=25) 
had a better prognosis (median (range) survival time: 3.96 (0.41-11.62) years). The survival probability of patients with medium entropy 
(n=25, 0.90 (0.30-10.77) years) and high entropy (n=25, 0.62 (0.28-10.21) years) was similar and poorer compared to patients with low 
entropy.
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Supplementary Figure S5: Comparison of DNA copy number entropy values between treatment group stratified by 
chromosome. Each bar represents a chromosome. Y-axis: statistical significance quantified as p-value, X-axis: chromosomes in 
numerical order. The black dashed horizontal line denotes the significance threshold, p = 0.05.
Supplementary Figure S6: Treatment group differences observed in our data. Each point in the plot denotes a feature. 
Y-axis: statistical significance quantified as false discovery rate (FDR), X-axis: chromosomes in numerical order. None of the feature passed 
the significant threshold FDR = 0.1 (-log10(0.1) = 1).
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Supplementary Table S1: Association of clinopathological variables not mentioned in the paper with DNA copy 
number entropy.
clinicopathological variables Association with entropy (p-value)
CS+S CS S
Grade of differentiation 0.655 0.056 0.551
Lymph node status (pN/ypN) 0.096 0.993 0.038
Depth of tumor invasion (pT/ypT) 0.096 0.074 0.910
Lymphatic channel invasion 0.059 0.426 0.112
Vnous or perineural invasion 0.596 0.067 0.475
Note that the p-value of the relationship between lymph node status and treatment group is below 0.05 for the S group. 
However, this is raw p-value prior to Bonferroni correction after which none of the p-values is below the signficance level.
